Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies
Introduction. The role of antiphospholipid antibody (APA) carriage in the pathogenesis of pregnancy failure is one of the most recently debated issues. To date, no unified therapeutic approach to immunotherapy of antiphospholipid syndrome (APS) in pregnancy exists. Intravenous immunoglobulins (IVIG)...
Saved in:
Main Authors: | D. R. Eremeeva (Author), M. S. Zainulina (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risks of reproductive loss and placenta-mediated pregnancy complications in women with antiphospholipid antibodies
by: Yu. S. Dolgova, et al.
Published: (2021) -
CIRCULATION OF ANTIPHOSPHOLIPID ANTIBODIES AND IVF FAILURES
by: N. S. Stuleva, et al.
Published: (2016) -
Complications and outcomes of pregnancy in patients with antiphospholipid antibodies during various treatment methods
by: Yu. S. Bagdasarova, et al.
Published: (2023) -
Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies
by: D. R. Eremeeva, et al.
Published: (2021) -
Application of the rotational thromboelastography/thromboelastometry for assessment of massive obstetric blood loss in a high risk group
by: D. R. Eremeeva, et al.
Published: (2020)